��������

Peter Hecht is a seasoned executive in the biotechnology and pharmaceutical sectors, currently serving as Chief Executive Officer at Tisento Therapeutics since July 2023. Previously, Peter has held significant leadership roles, including Co-Founder and CEO at Cyclerion from 2019 to July 2023 and Co-Founder and CEO at Ironwood Pharmaceuticals from 1998 to 2019. Peter also contributes to various organizations as a Board Member at Mythic Therapeutics, Inc. and Kallyope, and as an Advisory Board Member at Ariadne Labs. Peter's academic background includes a Doctor of Philosophy in Molecular Biology from the University of California, Berkeley, a Master of Science in Biology from Stanford University, and a Bachelor of Science in Mathematics from Stanford University.